IDWeek

Trials meet all primary aims, poising them to advance toward clinical use

Use of cefepime meanwhile resulted in more neurological dysfunction

One dose proved noninferior to triple-dose regimen in randomized trial

Antiviral protected older at-risk patients, but appeared to increase risk in teens

And second dose after 1 year appeared to add no extra protection

Findings may encourage increased pediatric vaccine uptake, researcher says

Association strongest with exclusive breastfeeding

Delabeling strategy carries little risk, needs minimal testing, and no specialist consult

While not quite as sensitive as saliva PCR testing, dried blood spot testing has promise

High mortality in outbreak linked to anesthesia in Mexico

Fostamatinib reduced time on supplemental oxygen, improved clinical status

Plus: Detecting viruses in wastewater and the maternal RSV vaccine for protecting infants

Those in long-term care facilities are particularly at risk, researcher says

Trials show upwards of 85% protection against more severe cases of respiratory syncytial virus